|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sexton R, Al Hallak M, Diab M and Azmi A:
Gastric cancer: A comprehensive review of current and future
treatment strategies. Cancer Metastasis Rev. 39:1179–1203. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schulz C, Schütte K, Mayerle J and
Malfertheiner P: The role of the gastric bacterial microbiome in
gastric cancer: Helicobacter pylori and beyond. Therap Adv
Gastroenterol. 12:17562848198940622019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ajani JA, D'Amico TA, Almhanna K, Bentrem
DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, et
al: Gastric cancer, version 3.2016, NCCN clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 14:1286–1312. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu T, Luo S, Libby P and Shi GP:
Cathepsin L-selective inhibitors: A potentially promising treatment
for COVID-19 patients. Pharmacol Ther. 213:1075872020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li C, Huang J, Cheng YC and Zhang YW:
Traditional Chinese medicine in depression treatment: From
molecules to systems. Front Pharmacol. 11:5862020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang J, Zhu X, Yuan P, Liu J, Wang B and
Wang G: Efficacy of traditional Chinese medicine combined with
chemotherapy in patients with non-small cell lung cancer (NSCLC): A
meta-analysis of randomized clinical trials. Support Care Cancer.
28:3571–3579. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y and Ha CY: Research progress on
musk and artificial propagation technique of forest musk deer.
Zhongguo Zhong Yao Za Zhi. 43:3806–3810. 2018.(In Chinese).
PubMed/NCBI
|
|
10
|
Zhou Z, Dun L, Wei B, Gan Y, Liao Z, Lin
X, Lu J, Liu G, Xu H, Lu C and An H: Musk ketone induces neural
stem cell proliferation and differentiation in cerebral ischemia
via activation of the PI3K/Akt signaling pathway. Neuroscience.
435:1–9. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu L and Cao Y: Native musk and synthetic
musk ketone strongly induced the growth repression and the
apoptosis of cancer cells. BMC Complement Altern Med. 16:5112016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Gao M, An J, Wang X, Jia Y, Xu J,
Zhu J, Cui J, Li W, Xing R, et al: Dysregulation of
MiR-30a-3p/gastrin enhances tumor growth and invasion through
STAT3/MMP11 pathway in gastric cancer. Onco Targets Ther.
13:8475–8493. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang L, Li J, Hu Z, Fan X, Cai T, Zhou H
and Pan H: A systematic review of the mechanisms underlying
treatment of gastric precancerous lesions by traditional Chinese
medicine. Evid Based Complement Alternat Med.
2020:91547382020.PubMed/NCBI
|
|
16
|
Wu F, Liu W, Feng H, Long L, Hou L and Hou
C: Application of traditional chinese medicines in postoperative
abdominal adhesion. Evid Based Complement Alternat Med.
2020:80734672020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tu Y: The discovery of artemisinin
(qinghaosu) and gifts from Chinese medicine. Nat Med. 17:1217–1220.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Xu C, Wong YK, Liao FL, Jiang T
and Tu Y: Malaria eradication. Lancet. 395:e692020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tu T: Artemisinin-A gift from traditional
Chinese medicine to the world (nobel lecture). Angew Chem Int Ed
Engl. 55:10210–10226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng GQ, Kenney PM and Lam LK: Isolation
and biological evaluation of potential cancer chemopreventive
agents from ambrette musk residue. J Pharm Sci. 81:950–953. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Api AM, Pfitzer EA and San RH: An
evaluation of genotoxicity tests with Musk ketone. Food Chem
Toxicol. 34:633–638. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sanger JM, Wang J, Gleason LM, Chowrashi
P, Dube DK, Mittal B, Zhukareva V and Sanger JW: Arg/Abl-binding
protein, a Z-body and Z-band protein, binds sarcomeric, costameric,
and signaling molecules. Cytoskeleton (Hoboken). 67:808–823. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kioka N, Ueda K and Amachi T: Vinexin,
CAP/ponsin, ArgBP2: A novel adaptor protein family regulating
cytoskeletal organization and signal transduction. Cell Struct
Funct. 27:1–7. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han L, Huang C and Zhang S: The
RNA-binding protein SORBS2 suppresses hepatocellular carcinoma
tumourigenesis and metastasis by stabilizing RORA mRNA. Liver Int.
39:2190–2203. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan B, Peng Z and Xing C: SORBS2, mediated
by MEF2D, suppresses the metastasis of human hepatocellular
carcinoma by inhibitiing the c-Abl-ERK signaling pathway. Am J
Cancer Res. 9:2706–2718. 2019.PubMed/NCBI
|
|
26
|
Zhao L, Wang W, Huang S, Yang Z, Xu L,
Yang Q, Zhou X, Wang J, Shen Q, Wang C, et al: The RNA binding
protein SORBS2 suppresses metastatic colonization of ovarian cancer
by stabilizing tumor-suppressive immunomodulatory transcripts.
Genome Biol. 19:352018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jie R, Zhu P, Zhong J, Zhang Y and Wu H:
LncRNA KCNQ1OT1 affects cell proliferation, apoptosis and fibrosis
through regulating miR-18b-5p/SORBS2 axis and NF-ĸB pathway in
diabetic nephropathy. Diabetol Metab Syndr. 12:772020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tong Y, Li Y, Gu H, Wang C, Liu F, Shao Y
and Li F: HSF1, in association with MORC2, downregulates ArgBP2 via
the PRC2 family in gastric cancer cells. Biochim Biophys Acta Mol
Basis Dis. 1864:1104–1114. 2018. View Article : Google Scholar : PubMed/NCBI
|
